BackIO Biotech Overview

IO Biotech Current Cash

IO Biotech's current cash is $31M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$30.66M
↓ 61.76% YoYΔ $-49.52M vs prior year quarter

Peer average

Loading

IO Biotech Current Cash History

Loading

IO Biotech vs. peers: Current Cash Comparison

Loading

IO Biotech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IO Biotech (IOBT) FAQ

IO Biotech posts a current cash of $31M as of September 2025. That compares with $80M in the prior-year period — down 61.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, IO Biotech's current cash was $80M. The latest reading is $31M — a 61.8% year-over-year decrease (period ending September 2025). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of IO Biotech's financial statement story. At $31M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IOBT's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; IO Biotech's other metric pages and overview cover the third.